Wordt geladen...
Treatment of Relapsed Acute Myeloid Leukemia
Relapse is still a common scenario in acute myeloid leukemia (AML) treatment and occurs in 40–50% of younger and the great majority of elderly patients. The prognosis in relapsed AML patients is generally poor but depends largely on the timing of relapse (early versus late) and the possibility of al...
Bewaard in:
| Gepubliceerd in: | Curr Treat Options Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer US
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7324428/ https://ncbi.nlm.nih.gov/pubmed/32601974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-020-00765-5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|